Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-018920
Filing Date
2017-11-09
Accepted
2017-11-09 17:02:36
Documents
50
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plxp20170930_10q.htm 10-Q 650129
2 EXHIBIT 31.1 ex_97176.htm EX-31.1 14770
3 EXHIBIT 31.2 ex_97177.htm EX-31.2 15480
4 EXHIBIT 32.1 ex_97178.htm EX-32.1 8654
  Complete submission text file 0001437749-17-018920.txt   3632835

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT plxp-20170930.xml EX-101.INS 502023
6 XBRL TAXONOMY EXTENSION SCHEMA plxp-20170930.xsd EX-101.SCH 45019
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20170930_cal.xml EX-101.CAL 36016
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20170930_def.xml EX-101.DEF 334883
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20170930_lab.xml EX-101.LAB 315807
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20170930_pre.xml EX-101.PRE 347283
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 171191736
SIC: 2834 Pharmaceutical Preparations